دورية أكاديمية

Clinical features and risk factors for Sjogren's syndrome patients suffering from oral candidiasis in Shanxi, China.

التفاصيل البيبلوغرافية
العنوان: Clinical features and risk factors for Sjogren's syndrome patients suffering from oral candidiasis in Shanxi, China.
المؤلفون: Xing Y; The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China., Shi H; The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China., Wang C; The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China., Yang Y; The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China. yangying80916@gmail.com.
المصدر: BMC oral health [BMC Oral Health] 2024 Jul 17; Vol. 24 (1), pp. 812. Date of Electronic Publication: 2024 Jul 17.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101088684 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6831 (Electronic) Linking ISSN: 14726831 NLM ISO Abbreviation: BMC Oral Health Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Candidiasis, Oral*/complications , Sjogren's Syndrome*/complications, Humans ; Male ; Female ; Risk Factors ; Middle Aged ; China/epidemiology ; Adult ; Saliva/microbiology ; Aged ; Retrospective Studies ; Sex Factors
مستخلص: Objectives: To investigate the clinical features and risk factors of Sjogren's Syndrome (SS) patients suffering from oral candidiasis and to provide a foundation for the prevention and treatment of oral candidiasis in SS patients.
Methods: The medical records of 479 SS patients admitted to the Second Hospital of Shanxi Medical University from 2018 to 2020 were analysed to determine the clinical characteristics and risk factors that influence the occurrence of oral candidiasis infection in SS patients.
Results: Patients with oral candidiasis were older than those without oral candidiasis (P < 0.05). Male SS patients had greater oral candidiasis rates (P < 0.05). Unstimulated whole saliva (UWS) and stimulated whole saliva (SWS) were both shown to be adversely associated with oral Candida infections (P < 0.001). Logistic regression revealed that a low UWS was an independent risk factor for oral Candida infections in SS patients (OR: 0.004, P = 0.023). Greater WBC counts (OR: 1.22, P < 0.001), lower haemoglobin levels (OR: 0.97, P = 0.007), lower serum albumin levels (OR: 0.88, P < 0.001), lower IgG levels (OR: 0.91, P = 0.011), lower IgA levels (OR: 0.75, P = 0.011), and lower IgM levels (OR: 0.91, P = 0.015) were found in patients with oral Candida infections. Patients on immunosuppressive medications (OR: 0.32, P = 0.011), particularly rapamycin (P < 0.001), had a decreased rate of oral Candida infections.
Conclusions: Patients with oral candidiasis were older than those without oral candidiasis. Male SS patients are more likely to have oral candidiasis. Individuals with lower UWS and SWS are more susceptible to oral Candida infection. Oral Candida infections in SS patients depend on their immunological status. Rapamycin may increase the abundance of Treg cells to reduce oral Candida infection in SS patients.
(© 2024. The Author(s).)
References: Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23(4):e391-e400. (PMID: 29924754)
Clin Immunol. 2014 May-Jun;152(1-2):1-9. (PMID: 24576620)
Int J Oral Sci. 2014 Sep;6(3):125-32. (PMID: 25105816)
J Int Med Res. 2020 Jul;48(7):300060520913149. (PMID: 32649852)
Med Oral Patol Oral Cir Bucal. 2020 Sep 1;25(5):e700-e705. (PMID: 32683379)
J Rheumatol. 2011 Nov;38(11):2428-31. (PMID: 21844143)
Oral Dis. 2018 Oct;24(7):1367-1378. (PMID: 29782688)
J Med Microbiol. 2013 Jan;62(Pt 1):10-24. (PMID: 23180477)
Oral Dis. 2019 Oct;25(7):1798-1808. (PMID: 31257663)
J Autoimmun. 2014 Jun;51:17-22. (PMID: 24637076)
J Am Dent Assoc. 2020 Oct;151(10):e92. (PMID: 32797944)
Pathogens. 2019 Apr 22;8(2):. (PMID: 31013590)
J Am Dent Assoc. 2008 May;139 Suppl:18S-24S. (PMID: 18460676)
J Clin Med. 2023 Feb 16;12(4):. (PMID: 36836095)
J Oral Microbiol. 2011 Jan 28;3:. (PMID: 21547018)
Med Oral Patol Oral Cir Bucal. 2010 Mar 01;15(2):e310-5. (PMID: 20190674)
Oral Dis. 2012 Oct;18(7):667-72. (PMID: 22548381)
BMJ. 2012 Jun 14;344:e3821. (PMID: 22700787)
Cell. 2015 Aug 27;162(5):1078-89. (PMID: 26317471)
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Feb;93(2):149-54. (PMID: 11862202)
Clin Exp Rheumatol. 2020 Jan-Feb;38(1):58-66. (PMID: 31074719)
N Engl J Med. 2018 Jul 05;379(1):96. (PMID: 29975035)
J Autoimmun. 2018 Feb;87:16-25. (PMID: 29191572)
J Immunol Res. 2019 May 20;2019:8101503. (PMID: 31236421)
Compend Contin Educ Dent. 2018 Jun;39(6):365-369; quiz 371. (PMID: 29847962)
Oral Dis. 2017 Apr;23(3):387-394. (PMID: 27998016)
Ann Rheum Dis. 2017 Jan;76(1):9-16. (PMID: 27789466)
Int Dent J. 2004 Jun;54(3):159-65. (PMID: 15218897)
N Engl J Med. 2018 Mar 08;378(10):931-939. (PMID: 29514034)
Cell. 2019 Mar 7;176(6):1340-1355.e15. (PMID: 30799037)
Arch Oral Biol. 2011 Oct;56(10):951-9. (PMID: 21676377)
J Biochem Mol Biol. 2006 May 31;39(3):229-39. (PMID: 16756750)
Clin Dermatol. 2016 Jul-Aug;34(4):487-94. (PMID: 27343964)
Clin Dev Immunol. 2013;2013:986789. (PMID: 24454481)
Int J Womens Dermatol. 2020 Aug 04;6(5):357-364. (PMID: 33898698)
J Intern Med. 2019 Jun;285(6):670-680. (PMID: 30892751)
Br Dent J. 2017 Nov 10;223(9):675-681. (PMID: 29123282)
Oral Dis. 2017 Oct;23(7):828-839. (PMID: 27717092)
Eur J Clin Microbiol Infect Dis. 2019 Nov;38(11):2005-2019. (PMID: 31372904)
Int J Environ Res Public Health. 2020 May 21;17(10):. (PMID: 32455849)
Rheumatol Int. 2020 Jun;40(6):873-879. (PMID: 32219478)
Mycoses. 2014 Mar;57(3):141-6. (PMID: 23952962)
Eur J Pharmacol. 2020 Feb 15;869:172872. (PMID: 31846626)
معلومات مُعتمدة: (ZB20242901) Shanxi Provincial Government Major Decision-Making Consultation Program; (202303021222331) Basic Research Program of Science and Technology Department of Shanxi Province; (2020-185) Research Project Supported by Shanxi Scholarship Council of China; (202303021211207) Natural Science Foundation of Shanxi Province
فهرسة مساهمة: Keywords: Candida albicans; Oral candidiasis; Oral lesions; Sjögren’s syndrome
تواريخ الأحداث: Date Created: 20240717 Date Completed: 20240717 Latest Revision: 20240720
رمز التحديث: 20240720
مُعرف محوري في PubMed: PMC11256585
DOI: 10.1186/s12903-024-04595-x
PMID: 39020326
قاعدة البيانات: MEDLINE
الوصف
تدمد:1472-6831
DOI:10.1186/s12903-024-04595-x